1) Refractory hemorrhage
难治性出血
2) intractable postpartum hemorrhage
难治性产后出血
1.
Objective To evaluate the value of uterine artery embolization in the treatment of intractable postpartum hemorrhage.
目的探讨子宫动脉栓塞术在难治性产后出血中的应用价值。
3) intractable epistaxis
难治性鼻出血
1.
Objective:To investigate the common nasal bleeding points and the management of intractable epistaxis.
目的:探讨难治性鼻出血的出血部位及检查治疗方法。
2.
Objective:To explore effective and convenient management for intractable epistaxis.
目的:寻找更快捷有效治疗难治性鼻出血的手段。
4) refractory hem orrhage
难治性大出血
5) RA
[英][rɑ:] [美][rɑ]
难治性贫血
1.
objective:On our daily work, we find that there is displasis in myelogram of some megablastic anemia (MA) and refractory anemia(RA) cases, therefore untypical MA should be differ from RA.
因此,不典型MA需要与难治性贫血(RA)进行鉴别。
2.
Methods: 14 patients with RA,23 patients with RAEB,and 16 patients with RAEB T were treated by administering stanozolol comined with folic acid and vatamine α D 3,cytarabine,and harringtonine,respectively.
方法 :分别采用康力龙 +叶酸 +a -D3、阿糖胞苷、三尖杉酯碱对 14例难治性贫血 (RA)、2 7例原始细胞增多的难治性贫血 (RAEB)、16例转变中原始细胞增多的难治贫血 (REBT)进行治疗。
6) refractory anemia
难治性贫血
1.
The Effect on VLA-5/CD49e of Marrow on Myelodyplastic Syndrome Refractory Anemia Patients by Busui Shengxue Granule and Retinotic Acid;
补髓生血颗粒加维甲酸对骨髓增生异常综合征—难治性贫血患者VLA-5/CD49e的影响
2.
The Clinical Obeservation of Treating Refractory Anemia of Myelodysplastic Syndrome Mainly with Marrow-Supplementing and Blood-Engendering Granule;
补髓生血颗粒为主治疗骨髓增生异常综合征之难治性贫血的临床观察
3.
To explore the treatment of refractory anemia (RA), 7 cases of myelodysplastic s yndrome (subtype of refractory anemia) were treated in combination of cyclosporin A (CsA) with st anozolol.
为了探讨难治性贫血治疗 ,对 7例骨髓增生异常综合征 (难治性贫血亚型 )患者 ,应用环胞菌素A(CsA)和康力龙进行了治疗 ,CsA用药时间为 5个月至 3年 ,平均为 13个月。
补充资料：难治性癫痫
难治性癫痫
intractable epilepsy
癫痫发作频繁，给予适当的抗痫药物后，药物血浆浓度在有效范围，仍不能控制发作者。多见于有下列危险因素者：有癫痫家族史；围生期异常；高发年龄小；合并有精神发育迟滞；长期未经正规治疗；发作频数、发作形式为婴儿痉挛、肌阵挛及复杂部分性发作者。若正规系统治疗仍不能奏效者，可考虑行手术治疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条